Tosoh's G7 Automated HPLC Analyzer builds off the success of the industry leading A1c 2.2 Plus with the addition of a ß-thalassemia Mode. The Tosoh G7 has both hemoglobin A1c and Beta-thalassemia prog...read more
"Excellent analyzer, easy to use and easy to troubleshoot. Quality control is consistent."
Tosoh's G7 Automated HPLC Analyzer builds off the success of the industry leading A1c 2.2 Plus with the addition of a ß-thalassemia Mode. The Tosoh G7 has both hemoglobin A1c and Beta-thalassemia programs to provide full patient profile. The Beta-thalassemia program quantifies hemoglobins F and A2, which are used in screening for Beta-thalassemia. In addition, the Beta-thalassemia program is used for presumptive identification of hemoglobins S, C and D and for screening for other hemoglobinopathies.
High Performance Liquid Chromatography HPLC is the preferred methodology for hemoglobinopathy screening and since the G7 can be used for both hemoglobin A1c and Beta-thalassemia testing, it is 2 instruments in 1! The G7 provides time and labor-savings with primary tube sampling, automated cap piercing and positive sample identification. Most importantly, with less than 2% CVs the G7 offers a high level of both precision and accuracy.
Switching Modes Switching between the hemoglobin A1c and Beta-thalassemia programs is very easy, simple and fast. Just remove the hemoglobin A1c reagents, replace them with the Beta-thalassemia reagents, and let the instrument do the rest. Once the buffers and column have been changed, the system is automatically primed and is ready to perform analysis within minutes.
G7 HPLC Analyzer Features
- Stable HbA1c results in 2.2 minutes - ß-thalassemia results in less than 8 minutes - Quantification of HbF and HbA2 - Multi-functional STAT sample position - Presumptive ID of hemoglobinopathies - Inventory management system - Easy, user-friendly software - Compact size - NGSP Certified
Write a review
Sharing your experience will help scientists like you. Achieve Reviewer Status and Win an iPad air (All reviews published will be entered into the next drawing on March 30th 2014).